Valsartan EP Impurity C
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

952652-79-8Valsartan EP Impurity C

● In Stock

Catalogue No.:VL152002
CAS No.:952652-79-8
Mol. Formula:C23H27N5O3
Mol. Weight:421.49 g/mol

Order Online

UNIT PRICE QTY STATUS ACTION
100 mg $390.00
● In Stock
We accept Credit Card Icons

Additional information on CAS 952652-79-8

Parent drug

Valsartan

IUPAC Name

(2S)-2-[butanoyl[[2′-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]amino]-3-methylbutanoic acid

Pharmacopoeial Synonyms

Valsartan Related Compound B

Other Synonyms

N-(1-Oxobutyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-L-valine

Smiles

CC(C)[C@@H](C(O)=O)N(C(CCC)=O)CC1=CC=C(C2=CC=CC=C2C3=NNN=N3)C=C1

InChI

InChI=1S/C23H27N5O3/c1-4-7-20(29)28(21(15(2)3)23(30)31)14-16-10-12-17(13-11-16)18-8-5-6-9-19(18)22-24-26-27-25-22/h5-6,8-13,15,21H,4,7,14H2,1-3H3,(H,30,31)(H,24,25,26,27)/t21-/m0/s1

Description

Valsartan EP Impurity C, also designated Valsartan Related Compound B or Valsartan N-Butyryl Analog, is a structurally defined synthetic process impurity of the angiotensin II receptor antagonist valsartan. CAS 952652-79-8; molecular formula C23H27N5O3; molecular weight 421.49 g/mol. The impurity differs from the parent drug by N-acyl homologation of the valine-derived amino functionality, consistent with side product formation during acylation or amidation steps in API synthesis. It is not a nitrosamine, but its presence is assessed within impurity profiling and related-substance control strategies. Quantification commonly relies on stability-indicating LC-MS/MS and LC-UV, with LC-HRMS for structural confirmation.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url